Trial Profile
Phase II Study of Suberoylanilide Hydroxamic Acid (SAHA) (NSC 701852) as Salvage Therapy in Metastatic Breast Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Oct 2016
Price :
$35
*
At a glance
- Drugs Vorinostat (Primary)
- Indications Advanced breast cancer
- Focus Biomarker; Therapeutic Use
- 07 Feb 2008 Status changed from in progress to completed.
- 02 Nov 2005 New trial record.